Takeda (TSE:4502/NYSE:TAK) today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can offer the possibility of clinical remission for ...
If IV opioids are in short supply, who gets pain relief — a teenager in agony with a crushed leg or an 80-year-old dying from ...
One dose of the active compound in ayahuasca significantly improves depressive symptoms in early stages of a clinical trial, according to a new study. View on euronews ...
Sepsis, a life-threatening response to infection, is a major cause of death in U.S. hospitals, and early treatment is critical. The flag prompted the charge nurse to instruct Hart to room the patient ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA SC™ (pembrolizumab injection), a new subcutaneous formulation of ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
Dr Ranj said can become life-threatening if not treated promptly with antibiotics ...
A WOMAN who was an hour away from death after using Katie Price’s ‘Del Boy’ BBL injector in the UK has revealed how she’s been left with PTSD. Bonnie-Louise Cooper, 27, is bravely sharing her ...
Daily Express US on MSN
Nightmare story of woman to created multiple personalities to escape horrific abuse
The story of Sybil, a woman who developed 16 personalities after alleged abuse, captivated millions in the 1970s but was ...
About 100 Australians die every week from a superbug infection, with newborn babies and the critically ill being at greatest risk of the rising threat.
Japan Patent Office issues a notice of allowance to Moleculin Biotech for patent application covering annamycin: Houston Thursday, February 19, 2026, 16:00 Hrs [IST] Moleculin Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results